Peter Merkel, MD, MPH

Boston University School of MedicineBoston, Massachusetts - 02118 Boston UniversityBoston, Massachusetts - 02118 Boston University School of Medicine ...Boston, Massachusetts - 02118 |
- CLINICAL TRIALS 9
- CONDITIONS13
- INTERVENTIONS6
- SINCE2006

Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
May 2010 - April 2016

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
December 2008 - February 2012

Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis
April 2006 - April 2016

Determining Disease Activity Biomarkers in Individuals With Churg-Strauss Syndrome
April 2006 - April 2016

Mycophenolate Mofetil in Systemic Sclerosis
December 2006 -

Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa
April 2006 - April 2016

A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Beh et Disease
August 2009 - July 2011

Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
April 2006 - April 2016

Determining Disease Activity Biomarkers in Individuals With Wegener's Granulomatosis and Microscopic Polyangiitis
April 2006 - April 2016
Scleroderma, Systemic
Scleroderma, Diffuse
Sclerosis
Vasculitis
Wegener Granulomatosis
Arteritis
Takayasu Arteritis
Aortic Arch Syndromes
Giant Cell Arteritis
Polymyalgia Rheumatica
Churg-Strauss Syndrome
Polyarteritis Nodosa
Behcet Syndrome
Placebo
Abatacept
Mycophenolate Mofetil
Plasma Exchange
Glucocorticoids
Apremilast (Cc-10004)



